In vitro determination of the efficacy of illicit synthetic cannabinoids at CB1 receptors.
Shivani SachdevV Kiran VemuriSamuel D BanisterMitchell LongworthMichael KassiouMarina J SantiagoAlexandros MakriyannisMark ConnorPublished in: British journal of pharmacology (2019)
All SCRAs tested showed substantially higher efficacy at CB1 receptors than ∆9 -THC, which may contribute to the adverse effects seen with these drugs but not ∆9 -THC.